Proposed Data Collections Submitted for Public Comment and Recommendations, 55515-55516 [E8-22594]
Download as PDF
<![CDATA[
Federal Register / Vol. 73, No. 187 / Thursday, September 25, 2008 / Notices
online by accessing the PACHA Web
site, https://www.pacha.gov.
Members of the public will have the
opportunity to provide comments at the
meeting. Pre-registration is required for
public comment. Any individual who
wishes to participate in the public
comment session must register online at
https://www.pacha.gov; registration for
public comment will not be accepted by
telephone. Public comment will be
limited to three minutes per speaker.
Any members of the public who wish to
have printed material distributed to
PACHA members for discussion at the
meeting should submit, at a minimum,
one copy of the materials to the
Committee Manager, PACHA no later
than close of business on October 14,
2008. Contact information for the
PACHA Committee Manager is listed
above.
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Dated: September 19, 2008.
Mary (Marty) McGeein,
Executive Director, Presidential Advisory
Council on HIV/AIDS.
[FR Doc. E8–22580 Filed 9–24–08; 8:45 am]
Background and Brief Description
Tobacco use remains the leading
preventable cause of death in the United
States despite the availability of
evidence-based treatments for tobacco
dependence, which include counseling
and FDA-approved pharmacotherapies.
To increase both the use of treatment by
smokers attempting to quit and the
number of smokers who quit
successfully, the Guide to Community
Preventive Services recommends
reducing the out-of-pocket cost of
effective tobacco-dependence
treatments, and the Public Health
Service (PHS) Clinical Practice
Guideline supports expanded insurance
coverage for tobacco-dependence
treatment.
Medicaid recipients have
approximately 50% greater smoking
prevalence than the overall U.S. adult
population, and they are
disproportionately affected by tobaccorelated disease and disability. In 2000,
approximately 32 million low-income
persons in the United States received
their health insurance coverage through
federally funded State Medicaid
programs, and approximately 11.5
million (36%) of these persons smoked.
Substantial action to improve coverage
of tobacco-dependence treatments
through Medicaid will be needed if the
United States is to achieve the 2010
National Health Objective of 12%
smoking prevalence among adults.
The amount and type of coverage for
tobacco-dependence treatment offered
by Medicaid has been collected for
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60-Day–08–0691]
mstockstill on PROD1PC66 with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 or send
comments to Maryam Daneshvar, CDC
Acting Reports Clearance Officer, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
VerDate Aug<31>2005
17:50 Sep 24, 2008
Jkt 214001
Proposed Project
State Medicaid Tobacco Coverage
Survey (OMB No. 0920–0691)—
Reinstatement—National Center for
Chronic Disease Prevention and Control
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).
PO 00000
Frm 00020
Fmt 4703
Sfmt 4703
55515
1998, 2000, 2001, 2002, 2003, 2005,
2006, and 2007. Surveys have been
funded by the Robert Wood Johnson
Foundation (RWJF) (1998, 2000–2003)
and the Centers for Disease Control and
Prevention (CDC) (2005–2007) (OMB
No. 0920–0691, expiration date 8/31/
2008). The most recent analysis of these
information collections demonstrated
that in 2006, 39 states provided
coverage for some FDA-approved
medications for the general Medicaid
population; however, only 17 states
provided some form of coverage for
counseling and only seven states
covered all FDA-approved medications
and at least one form of counseling for
all enrollees. Some progress has been
made in that the number of states
offering no benefits decreased from 15
in 2002 to eight in 2006.
CDC plans to request reinstatement of
OMB approval to collect similar
information about Medicaid coverage of
tobacco-dependence treatments during
the years 2008–2010. Respondents will
be Medicaid directors in all 50 states
and the District of Columbia. To
minimize burden, each respondent will
receive an electronic copy of the survey
pre-filled with the previous year’s
results. Respondents will only be asked
to record changes that occurred since
the time of the previous submission. In
addition, respondents will be asked to
answer new questions pertaining to the
recommendations made in the updated
PHS clinical practice guideline issued
in May of 2008 regarding coverage for
combination therapies, smokeless
tobacco use, and their familiarity with
and use of the 2000 PHS guideline. The
minor changes to be incorporated in the
revised survey instrument are not
expected to have a significant impact on
the overall burden estimate. As in
previous years, each respondent will
also attach a copy of the state’s
Medicaid coverage plan to their
completed survey, in order to assist the
research team with the interpretation of
responses.
The information to be collected will
allow CDC to continue monitoring
compliance with the most recent PHS
recommendations and the progress of
State Medicaid Programs toward the
2010 National Health Objectives and
Healthy People 2010 goals.
There are no costs to respondents
except the time to complete the survey.
E:\FR\FM\25SEN1.SGM
25SEN1
55516
Federal Register / Vol. 73, No. 187 / Thursday, September 25, 2008 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Respondents
No. of
respondents
No. of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
State Medicaid Programs ................................................................................
51
1
0.5
26
........................
........................
........................
26
Total ..........................................................................................................
Dated: September 16, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E8–22594 Filed 9–24–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Office of Community Services
Office of Community Services,
ACF, DHHS.
ACTION: Notice To Award a Program
Expansion Supplement to the National
Association for State Community
Services Program (NASCSP) in
Washington, DC.
mstockstill on PROD1PC66 with NOTICES
AGENCY:
CFDA#: 53.570.
Legislative Authority: Section
678A(a)(1)(A) of the Community
Services Block Grant (CSBG) Act of
1981, (Pub. L. 97–35) as amended by the
Community Opportunities,
Accountability, and Training and
Educational Services (COATES) Human
Services Reauthorization Act of 1998,
(Pub. L. 105–285) authorizes the
Secretary of Health and Human Services
(HHS) to use a percentage of
appropriated funds for training,
technical assistance, planning,
evaluation, performance measurement,
monitoring, assistance for States in
carrying out corrective actions and the
correction of programmatic deficiencies
of eligible entities under the CSBG Act.
Amount of Award: $125,000.
Project Period: 9/30/2007–9/29/2010.
Summary:
The purpose of this supplemental
request is for the NASCSP to further
improve the general capacity and
technical competency of states to
administer the Community Services
Block Grant (CSBG). Targeted assistance
will be provided to states for
improvement in the areas of state plan
development and Results Oriented
Management and Accountability
(ROMA) focused monitoring. Emerging
training and technical assistance needs
VerDate Aug<31>2005
17:50 Sep 24, 2008
Jkt 214001
for states and local agencies receiving
CSBG funds will also be assessed and a
plan will be developed for strategic
assistance in the areas identified.
Additionally, this supplemental aims to
enhance the capacity of the Office of
Community Services (OCS) to continue
to convene its Monitoring Task Force
(MTF) and provide updates on its
comprehensive response to the
Government Accountability Office’s
report on the CSBG program. Specific
emphasis will be placed on monitoring
states for compliance while encouraging
excellence
Contact for Further Information:
Josephine B. Robinson, Director, Office
of Community Services, 370 L’Enfant
Promenade, SW., Washington, DC
20047, Telephone: 202/401–9333.
Dated: September 16, 2008.
Josephine B. Robinson,
Director, OCS.
[FR Doc. E8–22476 Filed 9–24–08; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2008–N–0272]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Notification of a
Health Claim or Nutrient Content Claim
Based on an Authoritative Statement
of a Scientific Body
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by October 27,
2008.
ADDRESSES: To ensure that comments on
the information collection are received,
PO 00000
Frm 00021
Fmt 4703
Sfmt 4703
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–6974, or e-mailed to
baguilar@omb.eop.gov. All comments
should be identified with the OMB
control number 0910–0374. Also
include the FDA docket number found
in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT:
Jonna Capezzuto, Office of Information
Management (HFA–710), Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301–796–3794.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
Notification of a Health Claim or
Nutrient Content Claim Based on an
Authoritative Statement of a Scientific
Body—(OMB Control Number 0910–
0374—Extension)
Section 403(r)(2)(G) and (r)(3)(C) of
the Federal Food, Drug and Cosmetic
Act (the act) (21 U.S.C. 343(r)(2)(G) and
(r)(3)(C)), as amended by the FDA
Modernization Act of 1997, provides
that any person may market a food
product whose label bears a nutrient
content claim or a health claim that is
based on an authoritative statement of a
scientific body of the U.S. Government
or the National Academy of Sciences
(NAS). Under this section of the act, a
person that intends to use such a claim
must submit a notification of its
intention to use the claim 120 days
before it begins marketing the product
bearing the claim. In the Federal
Register of June 11, 1998 (63 FR 32102),
FDA announced the availability of a
guidance entitled ‘‘Guidance for
Industry: Notification of a Health Claim
or Nutrient Content Claim Based on an
Authoritative Statement of a Scientific
Body.’’ The guidance provides the
agency’s interpretation of terms central
to the submission of a notification and
the agency’s views on the information
that should be included in the
notification. The agency believes that
the guidance will enable persons to
E:\FR\FM\25SEN1.SGM
25SEN1
]]>Agencies
[Federal Register Volume 73, Number 187 (Thursday, September 25, 2008)]
[Notices]
[Pages 55515-55516]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-22594]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60-Day-08-0691]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960 or
send comments to Maryam Daneshvar, CDC Acting Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
State Medicaid Tobacco Coverage Survey (OMB No. 0920-0691)--
Reinstatement--National Center for Chronic Disease Prevention and
Control (NCCDPHP), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Tobacco use remains the leading preventable cause of death in the
United States despite the availability of evidence-based treatments for
tobacco dependence, which include counseling and FDA-approved
pharmacotherapies. To increase both the use of treatment by smokers
attempting to quit and the number of smokers who quit successfully, the
Guide to Community Preventive Services recommends reducing the out-of-
pocket cost of effective tobacco-dependence treatments, and the Public
Health Service (PHS) Clinical Practice Guideline supports expanded
insurance coverage for tobacco-dependence treatment.
Medicaid recipients have approximately 50% greater smoking
prevalence than the overall U.S. adult population, and they are
disproportionately affected by tobacco-related disease and disability.
In 2000, approximately 32 million low-income persons in the United
States received their health insurance coverage through federally
funded State Medicaid programs, and approximately 11.5 million (36%) of
these persons smoked. Substantial action to improve coverage of
tobacco-dependence treatments through Medicaid will be needed if the
United States is to achieve the 2010 National Health Objective of 12%
smoking prevalence among adults.
The amount and type of coverage for tobacco-dependence treatment
offered by Medicaid has been collected for 1998, 2000, 2001, 2002,
2003, 2005, 2006, and 2007. Surveys have been funded by the Robert Wood
Johnson Foundation (RWJF) (1998, 2000-2003) and the Centers for Disease
Control and Prevention (CDC) (2005-2007) (OMB No. 0920-0691, expiration
date 8/31/2008). The most recent analysis of these information
collections demonstrated that in 2006, 39 states provided coverage for
some FDA-approved medications for the general Medicaid population;
however, only 17 states provided some form of coverage for counseling
and only seven states covered all FDA-approved medications and at least
one form of counseling for all enrollees. Some progress has been made
in that the number of states offering no benefits decreased from 15 in
2002 to eight in 2006.
CDC plans to request reinstatement of OMB approval to collect
similar information about Medicaid coverage of tobacco-dependence
treatments during the years 2008-2010. Respondents will be Medicaid
directors in all 50 states and the District of Columbia. To minimize
burden, each respondent will receive an electronic copy of the survey
pre-filled with the previous year's results. Respondents will only be
asked to record changes that occurred since the time of the previous
submission. In addition, respondents will be asked to answer new
questions pertaining to the recommendations made in the updated PHS
clinical practice guideline issued in May of 2008 regarding coverage
for combination therapies, smokeless tobacco use, and their familiarity
with and use of the 2000 PHS guideline. The minor changes to be
incorporated in the revised survey instrument are not expected to have
a significant impact on the overall burden estimate. As in previous
years, each respondent will also attach a copy of the state's Medicaid
coverage plan to their completed survey, in order to assist the
research team with the interpretation of responses.
The information to be collected will allow CDC to continue
monitoring compliance with the most recent PHS recommendations and the
progress of State Medicaid Programs toward the 2010 National Health
Objectives and Healthy People 2010 goals.
There are no costs to respondents except the time to complete the
survey.
[[Page 55516]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
No. of Average burden
Respondents No. of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
State Medicaid Programs..................... 51 1 0.5 26
-------------------------------------------------------------------
Total................................... ............... ............... ............... 26
----------------------------------------------------------------------------------------------------------------
Dated: September 16, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E8-22594 Filed 9-24-08; 8:45 am]
BILLING CODE 4163-18-P
